期刊文献+

EphB2和EphrinB2及EphrinA1在喉癌组织中的表达及意义

The expression and significance of EphB2,EphrinB2 and EphrinA1 in laryngeal carcinoma tissues
下载PDF
导出
摘要 目的探讨EphB2、EphrinB2和EphrinA1与喉癌发生发展的关系及探讨喉癌的发病机制。方法应用流式细胞术检测喉癌组织、癌旁组织及喉部正常黏膜组织的EphB2和EphrinA1、EphrinB2蛋白表达的含量。基因蛋白以荧光指数(FI)>1.0为阳性表达,FI≤1.0为阴性表达。结果EphB2蛋白、EphrinB2蛋白、EphrinA1蛋白在喉癌组织中的阳性表达率分别高于癌旁组织和正常喉黏膜组织(P<0.05或<0.01)。在喉癌组织中,EphB2蛋白、EphrinB2蛋白、EphrinA1蛋白在淋巴结转移组的阳性表达率分别高于无淋巴结转移组(P<0.05);临床Ⅲ、Ⅳ期组的阳性表达率分别高于临床Ⅰ、Ⅱ期组(P<0.05或<0.01)。喉癌组织中EphB2蛋白与EphrinA1蛋白、EphrinB2蛋白有多元线性回归关系,且均为正相关(P<0.01)。结论EphB2蛋白和EphrinA1、EphrinB2蛋白高表达可能与喉癌的发生、发展有关。 Objective To investigate the relationship between the expression of EphB2, EphrinB2, EphrinA1 and the pathogenesis of laryngeal carcinoma, and to explore the mechanism of pathogenesis of laryngeal carcinoma. Methods The expression of EphB2, EphrinB2 and EphrinA1 protein with the flow eytometere Fluorescence index was defined as the quantitative expression index of EphB2, EphrinB2 and EphrinA1 protein. The FI value over 1.0 would be considered as positive expression, otherwise,as negative expression. Results The qualitative expressions of EphB2, EphrinB2 and EphrinA1 in laryngeal carcinoma tissues were obviously higher than those in para-carcinoma and in normal laryngeal mucosa tissues respectively ( P 〈 0.05 or 〈 0.01 ), in laryngeal carcinoma tissues, the qualitative expressions of EphB2, EphrinB2 and EphrinA1 with positive metastasis were remarkably higher than those without metastasis respectively( P 〈 0.05 or 〈 0.01 ), which in clinical stage Ⅲ, Ⅳ were significantly higher than those in clinical stage Ⅰ , Ⅱ respectively( P 〈0.05 or 〈0.01 ). There was a multiple linear regression correlation in the expression of EphB2, EphrinB2 and EphrinA1 in laryngeal carcinoma tissues, and which was a positive correlation. Conclusion The high expression of EphB2, EphrinB2 and EphrinAl may be related with the pathogenesis and development of laryngeal carcinoma.
出处 《河北医药》 CAS 2009年第11期1294-1296,共3页 Hebei Medical Journal
基金 河北省卫生厅科技攻关项目(编号:07315)
关键词 喉癌 EPHB2 EPHRINB2 EPHRINA1 流式细胞术 laryngeal carcinoma EphB2 Ephrin B2 EphrinA1 FCM
  • 相关文献

参考文献6

  • 1Kiyokawa E,Takai S, Tanaka M. Overexpression of ERK, an EPH family receptor protein tyrosine kinase in various human tumors. Cancer Research, 1994 : 3645-3650.
  • 2Zou JX, Wang B, Kalo MS,et al. An Eph receptor regulates integrin activity through R-Ras. Proc Natl Acad Sci USA,1999,96:13813-13818.
  • 3Liu W, Ahmad SA, Jung YD, et al. Coexpression of ephrin-Bs and their receptors in colon carcinoma. J Cancer,2002,94:934-939.
  • 4Hafner C, Schmitz G, Meyer S, et al. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem, 2004,50:490-499.
  • 5杨立,朱晓玲,景士兵,刘瑞雪,任秋华.胃癌组织、癌前病变及正常胃黏膜组织中EphB2的表达及病理学意义[J].中国肿瘤临床与康复,2008,15(4):339-342. 被引量:3
  • 6Meyer S, Hafner C, Guba M,et al. EphrinB2 overe-xpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. International Journal of Oneology,2005,27 : 1197-1206.

二级参考文献8

  • 1刘厚玉,董玲.胃癌.见:陈灏珠.实用内科学[M].第12版.北京:人民卫生出版社,2005.1880-1883.
  • 2Weidner N, Folkman J, Pozza F. Tumor angiogenesis: a new significant and independent prognostic in early-stage breast carcinoma [ J]. Natl Cancer Inst, 1992,84 (5) : 1875-1887.
  • 3Kiyokawa E,Takai S, Tanaka M. Overexpression of ERK, an EPH family receptor protein tyrosine kinase in various human tumors [J]. Cancer Res, 1994, 54(6) : 3645-3650.
  • 4Helbling BM, Sanlnier DM, Brandli AW. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus Laevis [ J ]. Development,2000,127 (2) : 269 -278.
  • 5Jensen PL. Eph-receptors and ephrins [ J ]. Stem Cell, 2000,78 (2)18-63.
  • 6Kimura H, Nakajima T, Kagawa K, et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry [J]. Liver, 1998.18(1) :14-19.
  • 7唐承微.胃癌.见:叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2004.394-395.
  • 8赵弘智.肿瘤组织血管内皮生长因子的血管生成作用[J].重庆医学,2002,31(2):136-139. 被引量:6

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部